This is a subtle tug of war, because p16 suppression promotes cancer. So maybe this pharmaceutical agent could be administered every so often, but not on a constant basis (which would paradoxically increase the chance for a variety of cancers to develop).
1 comment
[ 4.0 ms ] story [ 14.6 ms ] thread